Santa Cruz Newswire
Comprehensive Real-Time News Feed for Santa Cruz, CA.
Results 1 - 6 of 6 for "u:biospace.com" in Santa Cruz, CA
Summary: - Public access to Oxford Nanopore's MinIONa miniature sensing device enabled an international consortium to evaluate the technology and provide a standard protocol for its use; - Preliminary analysis of data generated in five very different laboratories indicates the performance and accuracy of the device is consistently good; - Data are freely available for re-analysis and innovation in the Nanopore analysis channel on F1000Research . 15 October 2015 - The MinION, a handheld DNA-sequencing device developed by Oxford Nanopore, has been tested and evaluated by an independent, international consortium coordinated by EMBL's European Bioinformatics Institute . Comment?
Dustin Adams listened as one of his colleagues narrated photos of her trip to Venice, Italy. What was remarkable was not the descriptions of the canal rides or beautiful churches, but rather that Adams's colleague was blind and was using a mobile app the 28-year-old UC Santa Cruz grad student had designed to recognize and describe the vacation shots she had taken. Comment?
Donation from storage industry leader includes 2.5 petabytes of storage for studying large-scale data storage challenges in genomics and other areas SANTA CRUZ, CA--Researchers in the Baskin School of Engineering at UC Santa Cruz are working with industry partner Seagate Technologies on new ways to structure and store massive amounts of genomic data. Seagate has donated data storage devices with a total capacity of 2.5 petabytes to support this effort. Comment?
The UC Santa Cruz Genomics Institute has received a $2 million grant from the W. M. Keck Foundation for ongoing research to develop a comprehensive map of human genetic variation. The Human Genome Variation Map will be a valuable new resource for medical researchers, as well as for basic research on human evolution and diversity. Comment?
Veteran vaccine researcher Phil Berman has developed a new approach based on an old vaccine and recent advances in HIV immunology SANTA CRUZ, CA--Phil Berman has been working to develop an AIDS vaccine for nearly 30 years, first at the pioneering biotech company Genentech, then as cofounder of VaxGen, and now at UC Santa Cruz, where he is the Baskin Professor of Biomolecular Engineering. Since his arrival at UC Santa Cruz in 2006, Berman has established a major vaccine research effort funded by a series of grants from the National Institutes of Health, including two new grants in 2014 totaling $2.6 million. Comment?
Theorem Clinical Research , a leading global contract research organization that optimizes trial conduct, has selected Scott P. Treiber, Ph.D., MBA, to spearhead biopharmaceutical development as executive vice president and general manager. "He brings expertise in central nervous system, oncology, cardiology, infectious diseases, respiratory and other prime therapeutic areas. Comment?
- « Previous
- Next »
Copyright © 2015 Topix LLC